Eggers, H., Stelmacher, R., Bögemann, M., Strauß, A., Thomas, C., Landmesser, J., . . . Ivanyi, P. (2025). Real-world experience with Lenvatinib Plus Everolimus (LEN+EVE) in patients with pretreated advanced renal cell carcinoma (RELEVANCE): A retrospective, multicenter case series. Clinical genitourinary cancer, 23(6), . https://doi.org/10.1016/j.clgc.2025.102449
Chicago-Zitierstil (17. Ausg.)Eggers, Hendrik, Ramona Stelmacher, Martin Bögemann, Arne Strauß, Christian Thomas, Johannes Landmesser, Stefanie Zschäbitz, und Philipp Ivanyi. "Real-world Experience with Lenvatinib Plus Everolimus (LEN+EVE) in Patients with Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case Series." Clinical Genitourinary Cancer 23, no. 6 (2025). https://doi.org/10.1016/j.clgc.2025.102449.
MLA-Zitierstil (9. Ausg.)Eggers, Hendrik, et al. "Real-world Experience with Lenvatinib Plus Everolimus (LEN+EVE) in Patients with Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case Series." Clinical Genitourinary Cancer, vol. 23, no. 6, 2025, https://doi.org/10.1016/j.clgc.2025.102449.